Suppr超能文献

尼日利亚西南部铜绿假单胞菌临床分离株中氨基糖苷类修饰酶基因(aac(6')-I和ant(2″)-I)的出现情况

Occurrence of aminoglycoside-modifying enzymes genes (aac(6')-I and ant(2″)-I) in clinical isolates of Pseudomonas aeruginosa from Southwest Nigeria.

作者信息

Odumosu Bamidele Tolulope, Adeniyi Bolanle A, Chandra Ram

机构信息

Department of Microbiology University of Lagos, Akoka Lagos; Department of Pharmaceutical Microbiology, University of Ibadan, Nigeria; Environmental Microbiology Section, Indian Institute of Toxicology Research, Lucknow, India.

Department of Pharmaceutical Microbiology, University of Ibadan, Nigeria.

出版信息

Afr Health Sci. 2015 Dec;15(4):1277-81. doi: 10.4314/ahs.v15i4.29.

Abstract

BACKGROUND

Enzymatic modification of aminoglycosides is the primary mechanism of resistance by Pseudomonas aeruginosa.

OBEJECTIVES

We investigated the occurrence and mechanism of aminoglycosides resistance in P. aeruginosa isolates from hospitals in SouthWest Nigeria.

METHODS

A total of 54 consecutive, non-duplicate clinical isolates of P. aeruginosa were studied for the presence of aminoglycosides -modifying enzymes (AMEs) by PCR amplification and sequencing of genes encoding AMEs.

RESULTS AND CONCLUSION

Two types of AME genes [aac (6') - I and ant (2″) - I] were found in 12 isolates out of 54. Seven strains harboured one or more types of enzymes of which aac (6') - I was the most frequently found gene (10/54 isolates, 18.5%). None of the isolates investigated in this study were positive for aph, aac (3) and aac (6″) - II genes. Prevalence of P. aeruginosa producing AME genes in this study may suggest aminoglycosides use in Nigeria. This study highlights need for functional antimicrobial surveillance system in Nigeria.

摘要

背景

氨基糖苷类药物的酶促修饰是铜绿假单胞菌耐药的主要机制。

目的

我们调查了尼日利亚西南部医院分离的铜绿假单胞菌中氨基糖苷类耐药的发生情况及机制。

方法

通过对编码氨基糖苷类修饰酶(AMEs)的基因进行PCR扩增和测序,研究了54株连续的、非重复的铜绿假单胞菌临床分离株中AMEs的存在情况。

结果与结论

在54株分离株中的12株中发现了两种类型的AME基因[aac(6')-I和ant(2″)-I]。7株菌株携带一种或多种类型的酶,其中aac(6')-I是最常发现的基因(10/54株分离株,18.5%)。本研究中调查的分离株均未检测到aph、aac(3)和aac(6″)-II基因呈阳性。本研究中产生AME基因的铜绿假单胞菌的流行情况可能提示尼日利亚存在氨基糖苷类药物的使用。本研究强调了尼日利亚建立功能性抗菌药物监测系统的必要性。

相似文献

3
Role of Aminoglycoside-Modifying Enzymes (AMEs) in Resistance to Aminoglycosides among Clinical Isolates of in the North of Iran.
Biomed Res Int. 2021 Aug 21;2021:7077344. doi: 10.1155/2021/7077344. eCollection 2021.
9
Aminoglycoside-modifying enzyme and 16S ribosomal RNA methyltransferase genes among a global collection of Gram-negative isolates.
J Glob Antimicrob Resist. 2019 Mar;16:278-285. doi: 10.1016/j.jgar.2018.10.020. Epub 2018 Oct 30.
10
Evaluation of Aminoglycoside and Carbapenem Resistance in a Collection of Drug-Resistant Pseudomonas aeruginosa Clinical Isolates.
Microb Drug Resist. 2018 Sep;24(7):1020-1030. doi: 10.1089/mdr.2017.0101. Epub 2017 Dec 20.

引用本文的文献

2
Emergence and Transfer of Plasmid-Harbored in a Clinical Multidrug-Resistant Strain.
Microorganisms. 2022 Sep 11;10(9):1818. doi: 10.3390/microorganisms10091818.
3
Pathogenesis of the Biofilm: A Review.
Pathogens. 2022 Feb 27;11(3):300. doi: 10.3390/pathogens11030300.
5
Role of Aminoglycoside-Modifying Enzymes (AMEs) in Resistance to Aminoglycosides among Clinical Isolates of in the North of Iran.
Biomed Res Int. 2021 Aug 21;2021:7077344. doi: 10.1155/2021/7077344. eCollection 2021.
8
Application of protein typing in molecular epidemiological investigation of nosocomial infection outbreak of aminoglycoside-resistant Pseudomonas aeruginosa.
Environ Sci Pollut Res Int. 2018 Aug;25(23):22437-22445. doi: 10.1007/s11356-017-0960-8. Epub 2017 Dec 16.
9
10

本文引用的文献

4
Potential of old-generation antibiotics to address current need for new antibiotics.
Expert Rev Anti Infect Ther. 2008 Oct;6(5):593-600. doi: 10.1586/14787210.6.5.593.
6
16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides.
Clin Infect Dis. 2007 Jul 1;45(1):88-94. doi: 10.1086/518605. Epub 2007 May 21.
7
Risk factors for ventilator-associated pneumonia by Pseudomonas aeruginosa in presence of recent antibiotic exposure.
Anesthesiology. 2006 Oct;105(4):709-14. doi: 10.1097/00000542-200610000-00016.
8
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
Antimicrob Agents Chemother. 2006 Jan;50(1):43-8. doi: 10.1128/AAC.50.1.43-48.2006.
9
Efflux-mediated antimicrobial resistance.
J Antimicrob Chemother. 2005 Jul;56(1):20-51. doi: 10.1093/jac/dki171. Epub 2005 May 24.
10
Aminoglycoside resistance in Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2005 Feb;49(2):479-87. doi: 10.1128/AAC.49.2.479-487.2005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验